Issue Date: January 1, 2018
JSR continues push into contract research
The Japanese chemical maker JSR has agreed to purchase the contract research firm Crown Bioscience International for about $400 million. Based in Taiwan, Crown offers patient-derived xenograft and animal models for multiple diseases. JSR expects Crown to have sales this year of about $90 million. JSR previously acquired the contract research and development firms KBI Biopharma, MBL, and Selexis.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society